Table 1. Summary of risk-stratified cystoscopic follow-up guidelines following treatment for NMIBC.
| Guideline | Low risk NMIBC | Intermediate risk NMIBC | High risk NMIBC |
|---|---|---|---|
| EAU (3) | • Cystoscopy at 3 months • Subsequent cystoscopy 9 months later • Then annually for 5 years • Stop follow-up after 5 years if tumour-free |
• Patients should have an “in-between (individualised)” follow-up schedule | • Cystoscopy and urine cytology at 3 months • Subsequent follow-up every 3 months for 2 years • Then every 6 months until 5 years • Life-long annual cystoscopies thereafter |
| AUA (4) | • Cystoscopy at 3 months • Subsequent cystoscopy 6–9 months later • Annually until 5 years • Shared-decision making about surveillance thereafter |
• Cystoscopy at 3 months • Subsequent cystoscopy and cytology every 3–6 months for 2 years • Then 6–12 months until 5 years • Life-long annual cystoscopies thereafter |
• Cystoscopy at 3 months • Subsequent cystoscopy every 3–4 months for 2 years • Then every 6 months until 5 years • Life-long annual cystoscopies thereafter |
| NICE (5) | • Cystoscopy at 3 months • Subsequent cystoscopy at 12 months • Do not offer prolonged cystoscopic follow-up after 12 months |
• Cystoscopy at 3 months • Subsequent cystoscopy at 9 and 18 months • Annually thereafter • Consider discharging patients to primary care if disease-free after 5 years |
• Cystoscopy every 3 months for 2 years • Then every 6 months for another 2 years • Life-long annual cystoscopies thereafter |
| NCCN (6) | • Cystoscopy at 3 and 12 months • Then annually for 5 years • Shared-decision making about surveillance thereafter |
• Cystoscopy at 3 months • Subsequent cystoscopy at 6 and 12 months • Then every 6 months for 1 year • Then annually until years 5 • Shared-decision making about surveillance thereafter |
• Cystoscopy every 3 months for 2 years • Then every 6 months for 2 years • Then annually until 10 years • Shared-decision making about surveillance thereafter |
AUA, American Urological Association; EAU, European Association of Urology; NCCN, National Comprehensive Cancer Network; NICE, National Institute for Health and Care Excellence; NMIBC, non-muscle invasive bladder cancer; MIBC, muscle invasive bladder cancer.